G-PUR® for Reduced Dietary Fumonisin Bioavailability
Not Applicable
Terminated
- Conditions
- Reduction of Dietary Fumonisin Bioavailability
- Interventions
- Device: 2.0g G-PUR®Other: Placebo
- First Posted Date
- 2020-07-31
- Last Posted Date
- 2020-11-16
- Lead Sponsor
- Glock Health, Science and Research GmbH
- Target Recruit Count
- 7
- Registration Number
- NCT04494178
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
G-Wound (VZ for Wound Treatment)
Not Applicable
Completed
- Conditions
- Wound HealWounds
- Interventions
- Device: VZ powder (purified clinoptilolite)Procedure: Standard of care (SoC)
- First Posted Date
- 2020-06-05
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- Glock Health, Science and Research GmbH
- Target Recruit Count
- 12
- Registration Number
- NCT04417647
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
G-PUR® for Symptomatic Treatment in Irritable Bowel Syndrome With Diarrhea
Not Applicable
- Conditions
- Irritable Bowel Syndrome With Diarrhea (IBS-D)
- Interventions
- Device: 2.0g G-PUR®, oral administrationDevice: Placebo, oral administration
- First Posted Date
- 2019-10-24
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- Glock Health, Science and Research GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT04138186
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
G-PUR® for Reduced Lead Bioavailability
Not Applicable
Completed
- Conditions
- Lead Exposure
- Interventions
- Device: G-PUR® 2x 2.0 g oral suspensionDevice: G-PUR® 1x 2.0 g oral suspensionDevice: Placebo oral suspension
- First Posted Date
- 2019-10-24
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- Glock Health, Science and Research GmbH
- Target Recruit Count
- 42
- Registration Number
- NCT04138693
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
© Copyright 2025. All Rights Reserved by MedPath